Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Koenraad S. Rhebergen. (2023) Extended high-frequency bone conduction audiometry Calibration of bone conductor transducers in the conventional and extended high-frequency range. International Journal of Audiology 62:2, pages 182-191.
Read now
Read now
Laura Leyssens, Bart Vinck, Catherine Van Der Straeten, Ingeborg Dhooge, Floris L. Wuyts & Leen K. Maes. (2021) The ototoxic potential of cobalt from metal-on-metal hip implants: a pilot study on the patient-reported auditory, vestibular, and general neurological outcome. International Journal of Audiology 60:1, pages 44-53.
Read now
Read now
Kelly A. King & Carmen C. Brewer. (2018) Clinical trials, ototoxicity grading scales and the audiologist’s role in therapeutic decision making. International Journal of Audiology 57:sup4, pages S19-S28.
Read now
Read now
Douglas Brungart, Jaclyn Schurman, Dawn Konrad-Martin, Kelly Watts, Jay Buckey, Odile Clavier, Peter G. Jacobs, Samuel Gordon & Marilyn F. Dille. (2018) Using tablet-based technology to deliver time-efficient ototoxicity monitoring. International Journal of Audiology 57:sup4, pages S78-S86.
Read now
Read now
Articles from other publishers (28)
Anna Rita Fetoni, Francesca Brigato, Eugenio De Corso, Daniela Lucidi, Bruno Sergi, Emanuele Scarano, Jacopo Galli & Antonio Ruggiero. (2022) Long-term auditory follow-up in the management of pediatric platinum-induced ototoxicity. European Archives of Oto-Rhino-Laryngology 279:10, pages 4677-4686.
Crossref
Crossref
Laura Leyssens, Bart Vinck, Catherine Van Der Straeten, Ingeborg Dhooge, Floris L. Wuyts, Philip Winnock de Grave, Filiep Bataillie, Jan Van Melkebeek, Koen De Smet, Ruth Van Hecke, Maya Danneels & Leen Maes. (2022) Assessing the Clinical Value of Objective and Patient-Reported Audiovestibular Outcome Measures in the Risk Estimation of Systemic Cobalt Toxicity for Patients With a Metal-on-Metal Hip Implant. Ear & Hearing 43:5, pages 1502-1514.
Crossref
Crossref
Colleen G. Le Prell. (2022) Prevention of Noise-Induced Hearing Loss Using Investigational Medicines for the Inner Ear: Previous Trial Outcomes Should Inform Future Trial Design. Antioxidants & Redox Signaling 36:16-18, pages 1171-1202.
Crossref
Crossref
Sofia Waissbluth, Juan Cristóbal Maass, Helmuth A. Sanchez & Agustín D. Martínez. (2022) Supporting Cells and Their Potential Roles in Cisplatin-Induced Ototoxicity. Frontiers in Neuroscience 16.
Crossref
Crossref
Kutluay Uluc, Prakash Ambady, Matthew K McIntyre, John Philip Tabb, Cymon N Kersch, Caleb S Nerison, Amy Huddleston, Jesse J Liu, Aclan Dogan, Ryan A Priest, Rongwei Fu, Joao Prola Netto, Dominic A Siler, Leslie L Muldoon, Seymur Gahramanov & Edward A Neuwelt. (2022) Safety of intra-arterial chemotherapy with or without osmotic blood–brain barrier disruption for the treatment of patients with brain tumors. Neuro-Oncology Advances 4:1.
Crossref
Crossref
Fernanda Soares Aurélio Patatt, Laura Faustino Gonçalves, Karina Mary de Paiva & Patrícia Haas. (2022) Ototoxic effects of antineoplastic drugs: a systematic review. Brazilian Journal of Otorhinolaryngology 88:1, pages 130-140.
Crossref
Crossref
Benyu Nan, Zirui Zhao, Kanglun Jiang, Xi Gu, Huawei Li & Xinsheng Huang. (2022) Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo. Acta Pharmaceutica Sinica B 12:1, pages 167-181.
Crossref
Crossref
Adriana M. Kahn, Kim R.M. Blenman, Steve T. Sonis & Maryam B. Lustberg. 2022. Strategies to Mitigate the Toxicity of Cancer Therapeutics. Strategies to Mitigate the Toxicity of Cancer Therapeutics
215
244
.
Angela Liou, Cassie Kline & Sabine Mueller. 2022. Neurological Complications of Systemic Cancer and Antineoplastic Therapy. Neurological Complications of Systemic Cancer and Antineoplastic Therapy
433
462
.
Annelot J. M. Meijer, Kathy H. Li, Beth Brooks, Eva Clemens, Colin J. Ross, Sharad R. Rassekh, Alex E. Hoetink, Martine van Grotel, Marry M. van den Heuvel‐Eibrink & Bruce C. Carleton. (2021) The cumulative incidence of cisplatin‐induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments. Cancer 128:1, pages 169-179.
Crossref
Crossref
Dana Keilty, Mohammad Khandwala, Zhihui Amy Liu, Vicky Papaioannou, Eric Bouffet, David Hodgson, Ryan Yee, Sharon Cushing, Normand Laperriere, Sameera Ahmed, Donald Mabbott, Vijay Ramaswamy, Uri Tabori, Annie Huang, Ute Bartels & Derek S. Tsang. (2021) Hearing Loss After Radiation and Chemotherapy for CNS and Head-and-Neck Tumors in Children. Journal of Clinical Oncology 39:34, pages 3813-3821.
Crossref
Crossref
Pattarawadee Prayuenyong, David M. Baguley, Corné J. Kros & Peter S. Steyger. (2021) Preferential Cochleotoxicity of Cisplatin. Frontiers in Neuroscience 15.
Crossref
Crossref
Yingying Wen, Shimin Zong, Tianyi Liu, Peiyu Du, Hao Li & Hongjun Xiao. (2021) Tauroursodeoxycholic acid attenuates cisplatin-induced ototoxicity by inhibiting the accumulation and aggregation of unfolded or misfolded proteins in the endoplasmic reticulum. Toxicology 453, pages 152736.
Crossref
Crossref
E C M Brown, C Caimino, C L Benton & D M Baguley. (2021) An audit of UK audiological practice in specialist paediatric oncology centres regarding hearing assessment of children at risk of ototoxicity due to chemotherapy. The Journal of Laryngology & Otology 135:1, pages 14-20.
Crossref
Crossref
Amélie Tillmanns, Claudia Lanvers-Kaminsky, Ross Parfitt, Annelot Meijer, Miklós Tóth, Adrian Münscher, Jörn D. Beck, Marry van den Heuvel-Eibrink & Antoinette am Zehnhoff-Dinnesen. 2021. Late Treatment Effects and Cancer Survivor Care in the Young. Late Treatment Effects and Cancer Survivor Care in the Young
27
48
.
Wendy Landier, Richard J. Cohn & Marry M. van den Heuvel-Eibrink. (2020) Hearing and Other Neurologic Problems. Pediatric Clinics of North America 67:6, pages 1219-1235.
Crossref
Crossref
Pattarawadee Prayuenyong, Anand V. Kasbekar, Deborah A. Hall & David M. Baguley. (2020) Audiovestibular clinician experiences and opinions about cisplatin vestibulotoxicity. European Archives of Oto-Rhino-Laryngology 277:12, pages 3283-3293.
Crossref
Crossref
Alaa Koleilat, Colin L. W. Driscoll, Lisa A. Schimmenti & Gayla L. Poling. (2020) Emerging Therapies and Approaches to Treat and Prevent Hearing Loss. Perspectives of the ASHA Special Interest Groups 5:5, pages 1147-1165.
Crossref
Crossref
Ashley Kita, Johnny Saldate, Courtney Chang, Nitika Chellappa, Jeremy Jong, Riley Matsuda, Andrew Schmidt, Brandon Shih, Iram Shafqat, Kari Schoettler, Shiv Acharya, Stephanie Seidlits & Larry Hoffman. (2020) Implantable Drug Reservoir Devices for Inner Ear Delivery of Pharmacotherapeutics. Otolaryngology–Head and Neck Surgery 163:4, pages 791-798.
Crossref
Crossref
Alexander C Rokohl, Nicole Skoetz, Joel M Mor, Niklas Loreck, Konrad R Koch & Ludwig M Heindl. (2020) Intravenous chemotherapy versus intra-arterial chemotherapy for retinoblastoma. Cochrane Database of Systematic Reviews.
Crossref
Crossref
David M. Baguley & Pattarawadee Prayuenyong. (2019) Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy. Cancer Chemotherapy and Pharmacology 85:2, pages 245-250.
Crossref
Crossref
Maria Antonietta Barbieri, Giuseppe Cicala, Paola Maria Cutroneo, Eleonora Mocciaro, Laura Sottosanti, Francesco Freni, Francesco Galletti, Vincenzo Arcoraci & Edoardo Spina. (2019) Ototoxic Adverse Drug Reactions: A Disproportionality Analysis Using the Italian Spontaneous Reporting Database. Frontiers in Pharmacology 10.
Crossref
Crossref
Leonard P. Rybak, Asmita Dhukhwa, Debashree Mukherjea & Vickram Ramkumar. (2019) Local Drug Delivery for Prevention of Hearing Loss. Frontiers in Cellular Neuroscience 13.
Crossref
Crossref
John M. McGregor, Nancy D. Doolittle, Emily Youngers, Susan D. Bell & Edward A. Neuwelt. 2019. Nervous System Drug Delivery. Nervous System Drug Delivery
193
208
.
Pattarawadee Prayuenyong, John A. Taylor, Stephanie E. Pearson, Rachel Gomez, Poulam M. Patel, Deborah A. Hall, Anand V. Kasbekar & David M. Baguley. (2018) Vestibulotoxicity Associated With Platinum-Based Chemotherapy in Survivors of Cancer: A Scoping Review. Frontiers in Oncology 8.
Crossref
Crossref
Kathleen C. M. Campbell & Colleen G. Le Prell. (2018) Drug-Induced Ototoxicity: Diagnosis and Monitoring. Drug Safety 41:5, pages 451-464.
Crossref
Crossref
Sameh E. Soliman, Crystal N. D'Silva, Helen Dimaras, Irakli Dzneladze, Helen Chan & Brenda L. Gallie. (2018) Clinical and genetic associations for carboplatin‐related ototoxicity in children treated for retinoblastoma: A retrospective noncomparative single‐institute experience. Pediatric Blood & Cancer 65:5.
Crossref
Crossref
Andrew M. Breglio, Aaron E. Rusheen, Eric D. Shide, Katharine A. Fernandez, Katie K. Spielbauer, Katherine M. McLachlin, Matthew D. Hall, Lauren Amable & Lisa L. Cunningham. (2017) Cisplatin is retained in the cochlea indefinitely following chemotherapy. Nature Communications 8:1.
Crossref
Crossref